A team from Google DeepMind and several universities introduces Aeneas, a generative (and free) AI model designed to help ...

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

AI-powered drug company spun out of Google’s DeepMind says human trials are ‘very close’ After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials.

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...

Demis Hassabis, chief of Google DeepMind, believes there's a 50% chance of achieving AGI within 5 years. AGI means ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis.

Two AI models have achieved gold medal standard for the first time in a prestigious competition for young mathematicians – ...

Expect AI-made prescription drugs to be ready for clinical trials in a couple of years, predicts Google DeepMind CEO By Sarah Jackson Andrew Brookes/Getty Images Feb 26, 2024, 1:11 PM PT ...

Google DeepMind unveiled GenCast, its AI tool for weather forecasts. GenCast outperformed existing forecasting systems in trials, Google DeepMind said. Better forecasting will allow for better ...

Demis Hassabis, Co-Founder and CEO of Google DeepMind and Nobel Prize Laureate in Chemistry 2024, attends the Artificial Intelligence (AI) Action Summit at the Grand Palais in Paris, France ...